Double mutation at the putative protein kinase C phosphorylation sites thr plus Thr 323 in the mouse leukotrieneD 4 receptor eliminates homologous desensitization

Cellular Physiology and Biochemistry

Volumn 31, Issue 2-3, 2013, Pages 366-378

  Jørgensen, Sune T ^a   Eriksen, Heidi N ^a   Dausell, Janni ^a   Jespersen, Thomas ^a   Lambert, Ian H ^a   Hoffmann, Else K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CysLT1; Desensitization; Xenopus laevis

Indexed keywords

CALCIUM ION; CHLORIDE ION; CYSTINE; LEUKOTRIENE D4 RECEPTOR; PEPTIDOLEUKOTRIENE; POTASSIUM CHANNEL; PROTEIN KINASE C; RNA; SERINE; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SWELLING; CELL VOLUME; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; HOMOLOGOUS DESENSITIZATION; IN VITRO STUDY; MOLECULAR BIOLOGY; MOUSE; MUTATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; XENOPUS LAEVIS; DESENSITIZATION; ELECTRONIC CELL SIZING; ELECTROPHYSIOLOGICAL PROCEDURES; ENZYME PHOSPHORYLATION; FEMALE; MOLECULAR CLONING; PHOSPHORYLATION; RECEPTOR DOWN REGULATION; ULTRAVIOLET SPECTROPHOTOMETRY; VOLTAGE CLAMP TECHNIQUE; WILD TYPE;

XENOPUS LAEVIS;

EID: 84874807416     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343374     Document Type: Article

References (54)

1. Murphy RC, Gijon MA: Biosynthesis and metabolism of leukotrienes. Biochem J 2007;405:379-395. (Pubitemid 47172035)
2. Rovati GE, Capra V: Cysteinyl-leukotriene receptors and cellular signals. ScientificWorldJournal 2007;7:1375-1392. (Pubitemid 47435434)
3. Singh RK, Gupta S, Dastidar S, Ray A: Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 2010;85:336-349.
4. Bosse Y, Stankova J, Rola-Pleszczynski M: Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia. Ann Allergy Asthma Immunol 2009;102:16-21.
5. Amlani S, Nadarajah T, McIvor RA: Montelukast for the treatment of asthma in the adult population. Expert Opin Pharmacother 2011;12:2119-2128.
6. Montuschi P, Peters-Golden ML: Leukotriene modifiers for asthma treatment. Clin Exp Allergy 2010;40:1732-1741.
7. Massoumi R, Nielsen CK, Azemovic D, Sjolander A: Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin. Exp Cell Res 2003;289:342-351. (Pubitemid 37117420)
8. Ohd JF, Nielsen CK, Campbell J, Landberg G, Lofberg H, Sjolander A: Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003;124:57-70. (Pubitemid 36055339)
9. Parhamifar L, Jeppsson B, Sjolander A: Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells. Carcinogenesis 2005;26:1988-1998. (Pubitemid 41637613)
10. Nielsen CK, Campbell JI, Ohd JF, Morgelin M, Riesbeck K, Landberg G, Sjolander A: A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 2005;65:732-742. (Pubitemid 40220345)
11. Mezhybovska M, Wikstrom K, Ohd JF, Sjolander A: The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J Biol Chem 2006;281:6776-6784. (Pubitemid 43847614)
12. Paruchuri S, Sjolander A: Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. J Biol Chem 2003;278:45577-45585. (Pubitemid 37432699)
13. Paruchuri S, Broom O, Dib K, Sjolander A: The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 2005;280:13538-13544. (Pubitemid 40517245)
14. Paruchuri S, Mezhybovska M, Juhas M, Sjolander A: Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 2006;25:6660-6665. (Pubitemid 44646193)
15. Lambert IH, Hoffmann EK, Pedersen SF: Cell volume regulation: Physiology and Pathophysiology. Acta Physiol Scand 2008;194:255-282.
16. Hoffmann EK, Lambert IH, Pedersen SF: Physiology of cell volume regulation in vertebrates. Physiol Rev2009;89:193-277.
17. Nilius B, Vriens J, Prenen J, Droogmans G, Voets T: TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol Cell Physiol 2004;286:C195-C205. (Pubitemid 38146342)
18. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B: Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003;424:434-438. (Pubitemid 36917492)
19. Hoffmann EK: Leukotriene D4 (LTD4) activates charybdotoxin-sensitive and-insensitive K+ channels in Ehrlich ascites tumor cells. Pflugers Arch 1999;438:263-268. (Pubitemid 29361744)
20. Hougaard C, Niemeyer MI, Hoffmann EK, Sepulveda FV: K+ currents activated by leukotriene D4 or osmotic swelling in Ehrlich ascites tumour cells. Pflugers Arch 2000;440:283-294. (Pubitemid 30414656)
21. Lambert IH: Regulation of the taurine content in Ehrlich ascites tumour cells. Adv Exp Med Biol 1998;442:269-276. (Pubitemid 28313082)
22. Lambert IH: Effect of arachidonic acid, fatty acids, prostaglandins, and leukotrienes on volume regulation in Ehrlich ascites tumor cells. J Membr Biol 1987;98:207-221.
23. Lambert IH: Leukotriene-D4 induced cell shrinkage in Ehrlich ascites tumor cells. J Membr Biol 1989;108:165-176. (Pubitemid 19138832)
24. Jørgensen NK, Lambert IH, Hoffmann EK: Role of LTD4 in the regulatory volume decrease response in Ehrlich ascites tumor cells. J Membr Biol 1996;151:159-173.
25. Lambert IH: Regulation of the Cellular Content of the Organic Osmolyte Taurine in Mammalian Cells. Neurochem Res 2004;29:27-63. (Pubitemid 38185786)
26. Nielsen CK, Lambert IH: Characterisation of the leukotriene D4 receptor in the Ehrlich ascites tumour cells. Acta Physiol Scand 1998;163:P15.
27. Hoffmann EK: Ion Channels Involved in Cell Volume Regulation: Effects on Migration, Proliferation, and Programmed Cell Death in Non Adherent EAT Cells and Adherent ELA Cells. Cell Physiol Biochem 2011;28:1061-1078.
28. Kelly E, Bailey CP, Henderson G: Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 2008;153:S379-S388. (Pubitemid 351340999)
29. Plouffe B, Yang X, Tiberi M: The third intracellular loop of D1 and D5 dopaminergic receptors dictates their subtype-specific PKC-induced sensitization and desensitization in a receptor conformation-dependent manner. Cell Signal 2012;24:106-118.
30. Vegesna RV, Mong S, Crooke ST: Leukotriene D4-induced activation of protein kinase C in rat basophilic leukemia cells. Eur J Pharmacol 1988;147:387-396. (Pubitemid 18076499)
31. Naik S, Billington CK, Pascual RM, Deshpande DA, Stefano FP, Kohout TA, Eckman DM, Benovic JL, Penn RB: Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J Biol Chem 2005;280:8722-8732. (Pubitemid 40409559)
32. Capra V, Accomazzo MR, Gardoni F, Barbieri S, Rovati GE: A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes. J Lipid Res 2010;51:1075-1084.
33. Deshpande DA, Pascual RM, Wang SW, Eckman DM, Riemer EC, Funk CD, Penn RB: PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. FASEB J 2007;21:2335-2342. (Pubitemid 47230663)
34. Capra V, Ravasi S, Accomazzo MR, Citro S, Grimoldi M, Abbracchio MP, Rovati GE: CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. J Cell Sci 2005;118:5625-5636. (Pubitemid 43079301)
35. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams DL Jr, Ford-Hutchinson AW, Caskey CT, Evans JF: Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789-793. (Pubitemid 29293175)
36. Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, Schmidt DB, Muccitelli RM, Jenkins O, Murdock PR, Herrity NC, Halsey W, Sathe G, Muir AI, Nuthulaganti P, Dytko GM, Buckley PT, Wilson S, Bergsma DJ, Hay DW: Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999;56:657-663. (Pubitemid 29406893)
37. Maekawa A, Kanaoka Y, Lam BK, Austen KF: Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci USA 2001;98:2256-2261. (Pubitemid 32209469)
38. Mollerup J, Jorgensen ST, Hougaard C, Hoffmann EK: Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes. Biochim Biophys Acta 2001;1517:455-459. (Pubitemid 32126601)
39. Jørgensen NK, Christensen S, Harbak H, Brown AM, Lambert IH, Hoffmann EK, Simonsen LO: On the role of calcium in the regulatory volume decrease (RVD) response in Ehrlich mouse ascites tumor cells. J Membr Biol 1997;157:281-299. (Pubitemid 27276170)
40. Mollerup J, Eriksen HN, Albertsen J, Wulff T, Lambert IH, Hoffmann EK: Homologous desensitisation of the mouse leukotriene B4 receptor involves protein kinase C-mediated phosphorylation of serine 127. Cell Physiol Biochem 2007;20:143-156. (Pubitemid 46956820)
41. Weber W: Ion currents of Xenopus laevis oocytes: state of the art. Biochim Biophys Acta 1999;1421:213-233. (Pubitemid 29460664)
42. Kirkegaard SS, Lambert IH, Gammeltoft S, Hoffmann EK: Activation of the TASK-2 channel after cell swelling is dependent on tyrosine phosphorylation. Am J Physiol Cell Physiol 2010;299:C844-C853.
43. Ma HW, Blitzer RD, Healy EC, Premont RT, Landau EM, Iyengar R: Receptor-evoked Cl-current in Xenopus oocytes is mediated through a beta-type phospholipase C. Cloning of a new form of the enzyme. J Biol Chem 1993;268:19915-19918. (Pubitemid 23278879)
44. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL Jr, Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF: Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000;275:30531-30536.
45. Thodeti CK, Massoumi R, Bindslev L, Sjolander A: Leukotriene D4 induces association of active RhoA with phospholipase C-gamma1 in intestinal epithelial cells. Biochem J 2002;365:157-163. (Pubitemid 34759968)
46. Ali H, Richardson RM, Tomhave ED, Didsbury JR, Snyderman R: Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. J Biol Chem 1993;268:24247-24254. (Pubitemid 23335411)
47. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, Mathiesen JM, Shah ST, Lyons JA, Caffrey M, Gellman SH, Steyaert J, Skiniotis G, Weis WI, Sunahara RK, Kobilka BK: Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011;477:549-555.
48. Unal H, Karnik SS: Domain coupling in GPCRs: the engine for induced conformational changes. Trends Pharmacol Sci 2012;33:79-88.
49. Thodeti CK, Nielsen CK, Paruchuri S, Larsson C, Sjolander A: The epsilon isoform of protein kinase C is involved in regulation of the LTD4-induced calcium signal in human intestinal epithelial cells. Exp Cell Res 2001;262:95-103. (Pubitemid 32980248)
50. Ng SW, Bakowski D, Nelson C, Mehta R, Almeyda R, Bates G, Parekh AB: Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression. Nature 2012;482:111-115.
51. Larsen AK, Jensen BS, Hoffmann EK: Activation of protein kinase C during cell volume regulation in Ehrlich mouse ascites tumor cells. Biochim Biophys Acta 1994;1222:477-482. (Pubitemid 24255652)
52. Hermoso M, Olivero P, Torres R, Riveros A, Quest AF, Stutzin A: Cell volume regulation in response to hypotonicity is impaired in HeLa cells expressing a protein kinase Calpha mutant lacking kinase activity. J Biol Chem 2004;279:17681-17689. (Pubitemid 38560534)
53. Lambert IH, Hoffmann EK, Christensen P: Role of prostaglandins and leukotrienes in volume regulation by Ehrlich ascites tumor cells. J Membr Biol 1987;98:247-256.
54. Niemeyer MI, Hougaard C, Hoffmann EK, Jorgensen F, Stutzin A, Sepulveda FV: Characterisation of a cell swelling-activated K+-selective conductance of ehrlich mouse ascites tumour cells. J Physiol 2000;524:757-767. (Pubitemid 30303623)